INDEPENDENT AUDITORS' CONSENT


We consent to the use in this Pre-Effective Amendment No. 1 to Registration
Statement No. 333-64218 of BioSante Pharmaceuticals, Inc. on Form SB-2 of our
report dated February 16, 2001 (which report expresses an unqualified opinion
and includes an explanatory paragraph referring to the developmental stage
nature of BioSante), appearing in the Prospectus, which is part of this
Registration Statement. We also consent to the reference to us under the heading
"Experts" in such Prospectus.


/s/ Deloitte & Touche LLP

Chicago, Illinois
September 13, 2001